Black Bird Biotech president Fabian Deneault is certainly sharpening the ax on the way to potentially shifting the biopesticide industry. From EPA registration to state approvals to proof of concept with major distributors, MiteXstream is shaping up to rewrite the agricultural industry’s love affair with pesticides.
Consequently, prospective shareholders are excited that something groundbreaking and innovative is shifting perceptions on biopesticides. However, moving on from the toxic products that can alter crops and put agricultural workers at risk is a massive undertaking.
Providing a safe alternative to pesticides that use poison to mitigate pests is at the heart of the MiteXstream effort. Consumers are more cautious than ever about the food on their family tables. Farmers are taking a second look at plant-based options to manage mold, mildew, and spider mites, and investors have been pining for a company in excellent financial health that has the potential to uplist and trade on NASDAQ. That MiteXStream edge means several vital things to the market:
- Use through the day of harvest without residual pesticide violations
- Protection for indoor and outdoor crops
- Mitigation of molds, mildews, and spider mites on coffee, cannabis, strawberry crops, and more
- When used at the prescribed dilution rate, a cost-effective eliminator of mites and their eggs
- Storage stability of the biopesticide
Black Bird Biotech President Fabian Deneault has said, “We are excited to get this great product into the hands of growers and our country’s great farmers, as wells farmers around the world.” The marketplace is echoing that excitement.
Testing and Efficacy
MiteXstreamTM represents a miticide ideal for mite control in integrated pest management while carrying minimal risk. With the rigorous biopesticide certification by the EPA, the company was able to demonstrate outstanding results from the acute toxicity test and the storage stability test as administered by an independent third party. The acute toxicity test is, in reality, a battery of six tests for oral, dermal, and inhalation toxicity, as well as eye irritation, dermal toxicity, and skin sensitization. All of which MiteXstream passed without issue.
Fabian Deneault found that the efficacy of the MiteXstream formulation for molds, mildews, and spider mites on his plants was something he knew the marketplace had to have. Finally, more than one billion pounds of pesticides going into crops in the U.S. was a chance to improve the way Americans are fed from its essential farms. If the preliminary findings from the 4-month MiteXstream efficacy testing are any indication, there is a strong future ahead with more state approvals on the horizon.
The MiteXStream Discovery
Before the forums were buzzing with word of a plant-based, food-grade biopesticide, Fabian Deneault was using the MiteXstream formulation to improve the health of his plants and consequently his daughter.
After spending six months in the hospital, four of which were in the ICU, his daughter had a terrible interaction with opioids that stopped her breathing, leaving Fabian to leap into action and perform CPR. It was a difficult time, and something had to change. “Dad, I know you’re not into medical marijuana…you don’t believe in it, but I want to try something because the opioids are going to kill me.” Devastating words for any father, but Fabian was not afraid to implement something new.
He would secure his medical marijuana license and begin his own grow in a nearly 7,000 sq. ft. operation that ended up helping more than 100 patients in western Montana. Like any farmer, he encountered pests, but he tackled them with a formulation that got other growers talking.
“Following nearly two years of testing MiteXstreamTM in our grows and watching the test plants grow free of spider mites, molds, and mildews, and grow more robustly, we are excited to be able to purchase MiteXstreamTM,” said Dylan Matteson, owner of We’d in Montana.
The product has consistently shown outstanding performances, and as a field-tested and lab-proven biopesticide, there is virtually nothing like it on the market. The performance standards are where investors would like to see them, and the revenue growth potential is impressive.
Black Bird Biotech has leadership with an innovative approach, a product with an established track record of efficacy, and the biopesticide market has been awaiting the arrival of both. However, shareholders are not likely to see the current price levels again and should determine if this company fits their portfolio. Blackbird Biotech is traded on the OTC Markets as BBBT.
DISCLAIMER: This article is strictly the author’s opinion. All stocks involve risks and the possibility of losing all of your investment. Please consider all risks before investing and consult with an investment advisor if you lack experience. Article provided in part by Strategic Innovations who are paid for by the companies for social media and research.
